Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic Subtrial in Adolescent Patients With Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial

NCT05511922 is registered in ClinicalTrials.gov with KalVista Pharmaceuticals, Ltd. as lead sponsor.

NCT NCT05511922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05511922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic Subtrial in Adolescent Patients With Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial
Lead sponsor
KalVista Pharmaceuticals, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
October 24, 2022
Completion date
May 27, 2026
Enrollment
11 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema